| Title : An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial - Shanbhag_2025_JAMA.Neurol__ |
| Author(s) : Shanbhag NM , Padmanabhan JL , Zhang Z , Harel BT , Jia H , Kangarloo T , Yin W , Dowling AV , Laurenza A , Khudyakov P , Galinsky K , Latzman RD , Simuni T , Weintraub D , Horak FB , Lustig C , Maruff P , Simen AA |
| Ref : JAMA Neurol , : , 2025 |
| Abstract : |
| PubMedSearch : Shanbhag_2025_JAMA.Neurol__ |
| PubMedID: 39761063 |
| Title : Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies - Alam_2023_Neurology__ |
| Author(s) : Alam JJ , Maruff P , Doctrow S , Chu HM , Conway J , Gomperts SN , Teunissen C |
| Ref : Neurology , : , 2023 |
| Abstract : |
| PubMedSearch : Alam_2023_Neurology__ |
| PubMedID: 37657939 |
| Title : Preclinical and randomized clinical evaluation of the p38alpha kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration - Jiang_2022_Nat.Commun_13_5308 |
| Author(s) : Jiang Y , Alam JJ , Gomperts SN , Maruff P , Lemstra AW , Germann UA , Stavrides PH , Darji S , Malampati S , Peddy J , Bleiwas C , Pawlik M , Pensalfini A , Yang DS , Subbanna S , Basavarajappa BS , Smiley JF , Gardner A , Blackburn K , Chu HM , Prins ND , Teunissen CE , Harrison JE , Scheltens P , Nixon RA |
| Ref : Nat Commun , 13 :5308 , 2022 |
| Abstract : |
| PubMedSearch : Jiang_2022_Nat.Commun_13_5308 |
| PubMedID: 36130946 |
| Title : Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans - Cho_2011_Psychopharmacology.(Berl)_218_513 |
| Author(s) : Cho W , Maruff P , Connell J , Gargano C , Calder N , Doran S , Fox-Bosetti S , Hassan A , Renger J , Herman G , Lines C , Verma A |
| Ref : Psychopharmacology (Berl) , 218 :513 , 2011 |
| Abstract : |
| PubMedSearch : Cho_2011_Psychopharmacology.(Berl)_218_513 |
| PubMedID: 21644059 |
| Title : Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil - Pietrzak_2009_J.Nutr.Health.Aging_13_268 |
| Author(s) : Pietrzak RH , Maruff P , Snyder PJ |
| Ref : J Nutr Health Aging , 13 :268 , 2009 |
| Abstract : |
| PubMedSearch : Pietrzak_2009_J.Nutr.Health.Aging_13_268 |
| PubMedID: 19262966 |